Alumis to Participate in Upcoming September Investor Conferences
Provided By GlobeNewswire
Last update: Aug 29, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies for patients with immune-mediated diseases, today announced that the Company will participate in the following investor conferences:
Read more at globenewswire.com11.49
-0.12 (-1.03%)
Find more stocks in the Stock Screener
ALMS Latest News and Analysis
